Search Results for "ivacaftor"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for ivacaftor. Results 1 to 4 of 4 total matches.
See also: Kalydeco
Vanzacaftor, Tezacaftor, and Deutivacaftor (Alyftrek) for Cystic Fibrosis
The Medical Letter on Drugs and Therapeutics • Mar 17, 2025 (Issue 1724)
and for deutivacaftor, a deuterated
form of ivacaftor. Trikafta, a twice-daily oral fixeddose
combination ...
The FDA has approved Alyftrek (Vertex), an oral
fixed-dose combination of the cystic fibrosis
transmembrane conductance regulator (CFTR)
modulators vanzacaftor, tezacaftor, and deutivacaftor,
for once-daily treatment of cystic fibrosis (CF) in
patients ≥6 years old who have at least one F508del
mutation or another responsive mutation in the
CFTR gene. This is the first approval for vanzacaftor
and for deutivacaftor, a deuterated form of ivacaftor.
Trikafta, a twice-daily oral fixed-dose combination of
elexacaftor, tezacaftor, and ivacaftor, is FDA-approved
for the same indication...
Med Lett Drugs Ther. 2025 Mar 17;67(1724):41-3 doi:10.58347/tml.2025.1724a | Show Introduction Hide Introduction
Correction
The Medical Letter on Drugs and Therapeutics • Mar 31, 2025 (Issue 1725)
of the
combination of elexacaftor, tezacaftor, and ivacaftor (Trikafta). Trikafta ivacaftor elexacaftor cystic ...
In our recent article on the combination of vanzacaftor, tezacaftor,
and deutivacaftor (Alyftrek) for cystic fibrosis (Med Lett Drugs Ther
2025; 67:41), Table 3 misstated the formulations and dosage of the
combination of elexacaftor, tezacaftor, and ivacaftor (Trikafta).
Med Lett Drugs Ther. 2025 Mar 31;67(1725):56 doi:10.58347/tml.2025.1725d | Show Introduction Hide Introduction
Table: Inhibitors and Inducers of CYP Enzymes, P-Glycoprotein, and Other Transporters (online only)
The Medical Letter on Drugs and Therapeutics • Feb 06, 2023 (Issue 1669)
juice
isavuconazonium
ivacaftor
letermovir
lomitapide
miconazole
netupitant
nilotinib ...
View the Inhibitors and Inducers of CYP Enzymes, P-Glycoprotein, and Other Transporters tables
Med Lett Drugs Ther. 2023 Feb 6;65(1669):e28-30 doi:10.58347/tml.2023.1669g | Show Introduction Hide Introduction
Treatment of Allergic Rhinitis and Allergic Conjunctivitis
The Medical Letter on Drugs and Therapeutics • Mar 31, 2025 (Issue 1725)
of the
combination of elexacaftor, tezacaftor, and ivacaftor (Trikafta). A
corrected version of the article appears ...
Initial treatment of allergic rhinitis (AR) depends
on the severity of symptoms and whether they are
intermittent or persistent (see Table 1).
Med Lett Drugs Ther. 2025 Mar 31;67(1725):49-56 doi:10.58347/tml.2025.1725a | Show Introduction Hide Introduction